Analisa DiFeo, Ph.D.
Affiliations: | 2008 | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Oncology, GeneticsGoogle:
"Analisa DiFeo"Parents
Sign in to add mentor| John A. Martignetti | grad student | 2008 | Mount Sinai School of Medicine | |
| (The role of KLF6 and KLF6-SV1 in the development and progression of epithelial ovarian cancer: Identification of a novel pro -survival protein that regulates apoptosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shang S, Yang J, Jazaeri AA, et al. (2019) Chemotherapy-induced distal enhancers drive transcriptional program to maintain the chemoresistant state in ovarian cancer. Cancer Research |
| Collins G, Mesiano S, DiFeo A. (2018) Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines. Reproductive Sciences (Thousand Oaks, Calif.). 1933719118779734 |
| Belur Nagaraj A, Kovalenko O, Avelar RA, et al. (2018) Mitotic Exit dysfunction through the deregulation of APC/C characterizes cisplatin resistant state in epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| McClinch K, A Avelar R, Callejas D, et al. (2018) Small molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer. Cancer Research |
| Morrow JJ, Bayles I, Funnell APW, et al. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nature Medicine |
| Nagaraj AB, Joseph P, Knarr M, et al. (2018) Abstract B66: miRNA 3’UTR activity driven enrichment of ovarian tumor-initiating cells (TICs) to overcome the barriers of heterogeneity and TIC plasticity Clinical Cancer Research. 24 |
| Hopp E, Joseph P, Nakayama J, et al. (2018) Identifying susceptibilities and pharmacodynamic biomarkers for mirvetuximab soravtansine in high-grade ovarian and endometrial cancer Gynecologic Oncology. 149: 57 |
| Collins G, Zolton J, Mesiano S, et al. (2018) The effects of metformin on cellular proliferation and steroid hormone receptor expression in patient derived low grade endometrial cancer cell lines: implications for reproductive sparing treatment using metformin Fertility and Sterility. 109: e21 |
| Nagaraj AB, Wang QQ, Joseph P, et al. (2017) Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment. Oncogene |
| Saygin C, Wiechert A, Rao VS, et al. (2017) CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors. The Journal of Experimental Medicine |